The Indian pharmaceutical sector faces mixed growth with a 12% YoY and 5% QoQ rise while IPM growth is projected at 8%.

Nagaraj Shetti, Technical Research Analyst at HDFC Securities, believes Monday's pattern could be considered as a High Wave, ...

These debt-free giants offer valuable insights into what it takes to succeed without relying on borrowed money.

Yes Securities has declared four stocks, from TCS to Nestle India, to be its top picks for October with strong target ...

One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years ...

Sanofi Consumer Healthcare India Ltd - Disclosures under Reg. 10 (5) in respect of acquisition under Reg. 10 (1) (a) of SEBI (SAST) Regulations, 2011 ...

The company entered the OTC business in 2007 and it has grown to have established brands such as Manforce, HealthOK, Prega ...

AM(IST)on Monday in a weak market. J B Chemicals & Pharmaceuticals Ltd.(up 2.83 per cent), Sanofi India Ltd.(up 1.36 per cent ...

Business Wire India Water is at the core of sustainable development, critical for the survival of humanity and the planet. As part of the Sustainabl ...

Sanofi plans to spin off its consumer healthcare division, which could be valued at over $16.8 billion. Private equity firms ...

Data also showed that the number of participants who experienced confirmed disability improvement increased by around two-fold. Liver enzyme elevations were observed in 4.1% of participants ...